Center for Cancer Cell Biology, Immunology and Infection, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, United States.
Edward Hines, Jr. VA Hospital, Hines, IL, United States.
Front Immunol. 2019 Aug 13;10:1911. doi: 10.3389/fimmu.2019.01911. eCollection 2019.
Proper orchestration of T lymphocyte development is critical, as T cells underlie nearly all responses of the adaptive immune system. Developing thymocytes differentiate in response to environmental cues carried from cell surface receptors to the nucleus, shaping a distinct transcriptional program that defines their developmental outcome. Our recent work has identified a previously undescribed role for the vacuolar ATPase (V-ATPase) in facilitating the development of murine thymocytes progressing toward the CD4 and CD8 αβ T cell lineages. Vav1 recombinase-mediated deletion of the isoform of the V-ATPase (a2V) in mouse hematopoietic cells leads to a specific and profound loss of peripheral CD4 and CD8 αβ T cells. Utilizing T cell-restricted Lck and CD4 strains, we further traced this deficiency to the thymus and found that a2V plays a cell-intrinsic role throughout intrathymic development. Loss of a2V manifests as a partial obstruction in the double negative stage of T cell development, and later, a near complete failure of positive selection. These data deepen our understanding of the biological mechanisms that orchestrate T cell development and lend credence to the recent focus on V-ATPase as a potential chemotherapeutic target to combat proliferative potential in T cell lymphoblastic leukemias and autoimmune disease.
T 淋巴细胞发育的适当调控至关重要,因为 T 细胞是适应性免疫系统几乎所有反应的基础。发育中的胸腺细胞对外界刺激做出反应,这些刺激通过细胞表面受体传递到细胞核,形成一个独特的转录程序,决定其发育结果。我们最近的工作发现,液泡型三磷酸腺苷酶(V-ATPase)在促进向 CD4 和 CD8 αβ T 细胞谱系发育的小鼠胸腺细胞发育方面具有先前未描述的作用。Vav1 重组酶介导的造血细胞 V-ATPase(a2V)的缺失导致外周 CD4 和 CD8 αβ T 细胞的特异性和严重缺失。利用 T 细胞限制性 Lck 和 CD4 株,我们进一步将这种缺陷追溯到胸腺,并发现 a2V 在整个胸腺内发育过程中发挥细胞内作用。a2V 的缺失表现为 T 细胞发育的双阴性阶段的部分阻塞,随后阳性选择几乎完全失败。这些数据加深了我们对调控 T 细胞发育的生物学机制的理解,并为最近将 V-ATPase 作为一种潜在的化疗靶点以对抗 T 细胞淋巴母细胞白血病和自身免疫性疾病中的增殖潜能的关注提供了依据。